Research Progress on High Cholesterol and Osteoarthritis

doi:10.12114/j.issn.1007-9572.2019.00.178

Abstract

Abstract: Studies have shown that osteoarthritis is not only affected by aging，but also affected by a variety of other factors.One of the risk factors may be high cholesterol level in the body.Although high cholesterol has been shown to promote cardiovascular diseases，its role in musculoskeletal disorders，especially osteoarthritis，is unclear.This paper will discuss how high cholesterol affects osteoarthritis and the molecular mechanisms by which it affects.This will be a new research direction and will provide a new strategy for the prevention and treatment of osteoarthritis.

Key words: Osteoarthritis, Hypercholesterolemia, Oxidative stress, Review

摘要： 研究指出，骨关节炎不仅受衰老影响，还受多种因素共同影响。其中一个危险因素可能是体内高胆固醇水平。尽管研究已经明确高胆固醇会促进心血管疾病的发生，但其在肌肉骨骼疾病，尤其是骨关节炎中的作用尚不清楚。本文将讨论高胆固醇如何影响骨关节炎，并介绍通过哪些分子机制对其产生影响。这将是一个新的研究方向，并对骨关节炎的防治及药物治疗提供新的策略。

关键词: 骨关节炎, 高胆固醇血症, 氧化应激, 综述

HAN Guangtao,LI Haohuan,CAI Weisong, et al. Research Progress on High Cholesterol and Osteoarthritis　[J]. Chinese General Practice, 2019, 22(32): 4015-4019. DOI: 10.12114/j.issn.1007-9572.2019.00.178.
韩广弢,李皓桓,蔡伟松等. 高胆固醇与骨关节炎的研究进展[J]. 中国全科医学, 2019, 22(32): 4015-4019. DOI: 10.12114/j.issn.1007-9572.2019.00.178.

References

［1］DAHAGHIN S，BIERMA-ZEINSTRA S M，KOES B W，et al．Do metabolic factors add to the effect of overweight on hand osteoarthritis? The rotterdam study［J］．Ann Rheum Dis，2007，66（7）：916-920．DOI：10.1136/ard.2005.045724.
［2］OLIVIERO F，LO NIGRO A，BERNARDI D，et al．A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides［J］．Clin Chim Acta，2012，413（1/2）：303-307．DOI：10.1016/j.cca.2011.10.019.
［3］PI H，ZHOU H T，JIN H，et al．Abnormal glucose metabolism in rheumatoid arthritis［J］．Biomed Res Int，2017，2017：9670434．DOI：10.1155/2017/9670434.
［4］PLEBANCZYK M，RADZIKOWSKA A，BURAKOWSKI T，et al．
Different secretory activity of articular and subcutaneous adipose tissues from rheumatoid arthritis and osteoarthritis patients［J］．Inflammation，2019，42（1）：375-386．DOI：10.1007/s10753-018-0901-9.
［5］赵金石，张宁.活动期类风湿关节炎患者高密度脂蛋白胆固醇代谢特点［J］．中华临床免疫和变态反应杂志，2016，10（4）：377-380．DOI：10.3969/j.issn.1673-8705.2016.04.011.
ZHAO J S，ZHANG N.Characteristic of high density lipoprotein cholesterol in active rheumatoid arthritis patients［J］．Chinese Journal of Allergy & Clinical Immunology，2016，10（4）：377-380．DOI：10.3969/j.issn.1673-8705.2016.04.011.
［6］慈维苹，潘丽丽，万瑾，等．中老年类风湿关节炎患者合并冠状动脉粥样硬化性心脏病的发病风险及相关因素研究［J］．中国医药，2016，11（5）：629-633．DOI：10.3760/cma.j.issn.1673-4777.2016.05.002.
CI W P，PAN L L，WAN J，et al．Relative factors of coronary artery disease in middle-aged and elderly patients with rheumatoid arthritis［J］．China Medicine，2016，11（5）：629-633．DOI：10.3760/cma.j.issn.1673-4777.2016.05.002.
［7］BAGGE E，BJELLE A，EDéN S，et al．Factors associated with radiographic osteoarthritis：results from the population study 70-year-old people in G?teborg［J］．J Rheumatol，1991，18（8）：1218-1222.
［8］MA X，ZHAO J Y，ZHAO Z L，et al．Propofol attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production through enhancing apoM and foxa2 expression in HepG2 cells［J］．Inflammation，2015，38（3）：1329-1336．DOI：10.1007/s10753-014-0104-y.
［9］TSEZOU A，ILIOPOULOS D，MALIZOS K N，et al．Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes［J］．J Orthop Res，2010，28（8）：1033-1039．DOI：10.1002/jor.21084.
［10］YU F，ZENG H，LEI M，et al．Effects of SIRT1 gene knock-out via activation of SREBP2 protein-mediated PI3K/AKT signaling on osteoarthritis in mice［J］．J Huazhong Univ Sci Technol Med Sci，2016，36（5）：683-690．DOI：10.1007/s11596-016-1645-0.
［11］谢静，史栋梁，郭会卿.SREBP-2沉默抑制衣霉素诱导的软骨细胞内质网应激［J］．中国病理生理杂志，2016，32（7）：1291-1296．DOI：10.3969/j.issn.1000-4718.2016.07.022.
XIE J，SHI D L，GUO H Q.Effect of SREBP-2 silencing on tunicamycin-induced endoplasmic reticu-lum stress in chondrocytes［J］．Chinese Journal of Pathophysiology，2016，32（7）：1291-1296．DOI：10.3969/j.issn.1000-4718.2016.07.022.
［12］TARANG S，WESTON M D.Macros in microRNA target identification［J］．RNA Biology，2014，11（4）：324-333．DOI：10.4161/rna.28649.
［13］CATRINA A I，SVENSSON C I，MALMSTR?M V，et al．Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis［J］．Nat Rev Rheumatol，2017，13（2）：79-86．DOI：10.1038/nrrheum.2016.200.
［14］GIERMAN L M，VAN DER HAM F，KOUDIJS A，et al．Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice［J］．Arthritis Rheum，2012，64（4）：1172-1181．DOI：10.1002/art.33443.
［15］GIERMAN L M，KüHNAST S，KOUDIJS A，et al．Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE3Leiden.CETP mice——a translational model for atherosclerosis［J］．Ann Rheum Dis，2014，73（5）：921-927．DOI：10.1136/annrheumdis-2013-203248.
［16］DE MUNTER W，VAN DEN BOSCH M H，SL?ETJES A W，et al．High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis［J］．Osteoarthr Cartil，2016，24（5）：844-855．DOI：10.1016/j.joca.2015.11.016.
［17］DE MUNTER W，BLOM A B，HELSEN M M，et al．Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis［J］．Arthritis Res Ther，2013，15（6）：R178．DOI：10.1186/ar4367.
［18］TIKU M L，SHAH R，ALLISON G T.Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation.Possible role in cartilage aging and the pathogenesis of osteoarthritis［J］．J Biol Chem，2000，275（26）：20069-20076．DOI：10.1074/jbc.M907604199.
［19］FARNAGHI S，PRASADAM I，CAI G P，et al．Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis［J］．FASEB J，2017，31（1）：356-367．DOI：10.1096/fj.201600600R.
［20］LE CLANCHE S，BONNEFONT-ROUSSELOT D，SARI-ALI E，et al．Inter-relations between osteoarthritis and metabolic syndrome：a common link?［J］．Biochimie，2016，121：238-252．DOI：10.1016/j.biochi.2015.12.008.
［21］COURTIES A，SELLAM J，BERENBAUM F.Metabolic syndrome-associated osteoarthritis［J］．Curr Opin Rheumatol，2017，29（2）：214-222．DOI：10.1097/BOR.0000000000000373.
［22］NIU J，CLANCY M，ALIABADI P，et al．Metabolic syndrome，its components，and knee osteoarthritis：the Framingham osteoarthritis study［J］．Arthritis Rheumatol，2017，69（6）：1194-1203．DOI：10.1002/art.40087.
［23］ONUORA S.Osteoarthritis：metabolic syndrome and risk of knee OA［J］．Nat Rev Rheumatol，2017，13（5）：257．DOI：10.1038/nrrheum.2017.41.
［24］TANG C R，HOUSTON B A，STOREY C，et al．Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages［J］．J Lipid Res，2016，57（5）：848-857．DOI：10.1194/jlr.M065797.
［25］WEI J，ZHANG Y Y，LUO J，et al．The GARP complex is involved in intracellular cholesterol transport via targeting NPC2 to lysosomes［J］．Cell Rep，2017，19（13）：2823-2835．DOI：10.1016/j.celrep.2017.06.012.
［26］KROLS M，BULTYNCK G，JANSSENS S.ER-mitochondria contact sites：a new regulator of cellular calcium flux comes into play［J］．J Cell Biol，2016，214（4）：367-370．DOI：10.1083/jcb.201607124.
［27］ZHANG T，GHAEMMAGHAMI S.Global analysis of cellular protein flux quantifies the selectivity of basal autophagy［J］．Autophagy，2016，12（8）：1411-1412．DOI：10.1080/15548627.2016.1190891.
［28］BARANOVA I N，SOUZA A C，BOCHAROV A V，et al．Human SR-BI and SR-BII potentiate lipopolysaccharide-induced inflammation and acute liver and kidney injury in mice［J］．J Immunol，2016，196（7）：3135-3147．DOI：10.4049/jimmunol.1501709.
［29］VELAGAPUDI S，YALCINKAYA M，PIEMONTESE A，et al．
VEGF-A regulates cellular localization of SR-BI as well as transendothelial transport of HDL but not LDL［J］．Arterioscler Thromb Vasc Biol，2017，37（5）：794-803．DOI：10.1161/ATVBAHA.117.309284.
［30］LUK F S，KIM R Y，LI K，et al．Immunosuppression with FTY720 reverses cardiac dysfunction in hypomorphic ApoE mice deficient in SR-BI expression that survive myocardial infarction caused by coronary atherosclerosis［J］．J Cardiovasc Pharmacol，2016，67（1）：47-56．DOI：10.1097/FJC.0000000000000312.
［31］BOCHAROV A V，WU T H，BARANOVA I N，et al．Synthetic amphipathic helical peptides targeting CD36 attenuate lipopolysaccharide-induced inflammation and acute lung injury［J］．J Immunol，2016，197（2）：611-619．DOI：10.4049/jimmunol.1401028.
［32］NELSON J K，KOENIS D S，SCHEIJ S，et al．EEPD1 is a novel LXR target gene in macrophages which regulates ABCA1 abundance and cholesterol efflux［J］．Arterioscler Thromb Vasc Biol，2017，37（3）：423-432．DOI：10.1161/ATVBAHA.116.308434.
［33］BUSH J R，BéRUBé N G，BEIER F.A new prescription for growth? Statins，cholesterol and cartilage homeostasis［J］．Osteoarthr Cartil，2015，23（4）：503-506．DOI：10.1016/j.joca.2015.01.002.
［34］FARNAGHI S，CRAWFORD R，XIAO Y，et al．Cholesterol metabolism in pathogenesis of osteoarthritis disease［J］．Int J Rheum Dis，2017，20（2）：131-140．DOI：10.1111/1756-185X.13061.
［35］WU C L，KIMMERLING K A，LITTLE D，et al．Serum and synovial fluid lipidomic profiles predict obesity-associated osteoarthritis，synovitis，and wound repair［J］．Sci Rep，2017，7：44315．DOI：10.1038/srep44315.
［36］GE Z Z，WEI Z，PENG J M，et al．Persimmon tannin regulates the expression of genes critical for cholesterol absorption and cholesterol efflux by LXRα independent pathway［J］．J Funct Foods，2016，23：283-293．DOI：10.1016/j.jff.2016.02.033.
［37］ALI S A，AL-JAZRAWE M，MA H，et al．Regulation of cholesterol homeostasis by hedgehog signaling in osteoarthritic cartilage［J］．Arthritis Rheumatol，2016，68（1）：127-137．DOI：10.1002/art.39337.
［38］向正宗，陈剑锋.Hedgehog信号通路在骨性关节炎中的研究进展［J］．海南医学，2016，27（23）：3887-3889．DOI：10.3969/j.issn.1003-6350.2016.23.033.
XIANG Z Z，CHEN J F.Progress of the Hedgehog signaling pathway in osteoarthritis［J］．Hainan Medical Journal，2016，27（23）：3887-3889．DOI：10.3969/j.issn.1003-6350.2016.23.033.
［39］宋先兵，张俊强，曹威，等．Hedgehog信号通路阻断剂环巴胺体外对佐剂性关节炎大鼠的关节软骨细胞增殖的影响［J］．解剖学报，2016，47（6）：763-768．DOI：10.16098/j.issn.0529-1356.2016.06.007.
SONG X B，ZHANG J Q，CAO W，et al．Effect of the Hedgehog signaling pathway blockers cyclopamine on the articular cartilage cell proliferation of adjuvant arthritis rat in vitro［J］．Acta Anatomica Sinica，2016，47（6）：763-768．DOI：10.16098/j.issn.0529-1356.2016.06.007.
［40］鲁轩源，钱宇.骨关节炎中骨赘形成及影响因素的研究进展［J］．中华骨科杂志，2017，37（1）：52-58．DOI：10.3760/cma.j.issn.0253-2352.2017.01.008.
LU X Y，QIAN Y.Advances in the development and influence factors of osteophytes in osteoarthritis［J］．Chinese Journal of Orthopaedics，2017，37（1）：52-58．DOI：10.3760/cma.j.issn.0253-2352.2017.01.008.
［41］SMITH A M，LINGARD L，HESLOP P，et al．Vascular disease as a cause of death in patients with severe disability due to osteoarthritis and rheumatoid arthritis［J］．Springerplus，2015，4：328．DOI：10.1186/s40064-015-1108-2.
［42］SHOELSON S E，HERRERO L，NAAZ A.Obesity，inflammation，and insulin resistance［J］．Gastroenterology，2007，132（6）：2169-2180．DOI：10.1053/j.gastro.2007.03.059.
［43］JIN X Z，BEGUERIE J R，ZHANG W Y，et al．Circulating C reactive protein in osteoarthritis：a systematic review and meta-analysis［J］．Ann Rheum Dis，2015，74（4）：703-710．DOI：10.1136/annrheumdis-2013-204494.
［44］PUZIANOWSKA-KUZNICKA M，OWCZARZ M，WIECZOROWSKA-TOBIS K，et al．Interleukin-6 and C-reactive protein，successful aging，and mortality：the PolSenior study［J］．Immun Ageing，2016，13：21．DOI：10.1186/s12979-016-0076-x.
［45］ZHANG M，LI L，XIE W，et al．Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation［J］．Atherosclerosis，2016，248：149-159．DOI：10.1016/j.atherosclerosis.2016.03.008.
［46］戴辑，张弢.非人灵长类的光遗传学研究进展［J］．生物化学与生物物理进展，2016，43（4）：354-360．DOI：10.16476/j.pibb.2016.0113.
DAI J，ZHANG T.The progress of optogenetic studies in nonhuman primates［J］．Progress in Biochemistry and Biophysics，2016，43（4）：354-360．DOI：10.16476/j.pibb.2016.0113.
［47］FRANCISCO V，PéREZ T，PINO J，et al．Biomechanics，obesity，and osteoarthritis.The role of adipokines：when the levee breaks［J］．J Orthop Res，2018，36（2）：594-604．DOI：10.1002/jor.23788.
［48］YIN F，SANCHETI H，LIU Z G，et al．Mitochondrial function in ageing：coordination with signalling and transcriptional pathways［J］．J Physiol（Lond），2016，594（8）：2025-2042．DOI：10.1113/JP270541.
［49］RIDOUT K K，CARPENTER L L，TYRKA A R.The cellular sequelae of early stress：focus on aging and mitochondria［J］．Neuropsychopharmacology，2016，41（1）：388-389．DOI：10.1038/npp.2015.301.
［50］MARTIN L A，KENNEDY B E，KARTEN B.Mitochondrial cholesterol：mechanisms of import and effects on mitochondrial function［J］．J Bioenerg Biomembr，2016，48（2）：137-151．DOI：10.1007/s10863-014-9592-6.
［51］BERMúDEZ-CARDONA J，VELáSQUEZ-RODRíGUEZ C.Profile of free fatty acids and fractions of phospholipids，cholesterol esters and triglycerides in serum of obese youth with and without metabolic syndrome［J］．Nutrients，2016，8（2）：54．DOI：10.3390/nu8020054.
［52］RíOS-MARCO P，MARCO C，CUETO F J，et al．Pleiotropic effects of antitumour alkylphospholipids on cholesterol transport and metabolism［J］．Exp Cell Res，2016，340（1）：81-90．DOI：10.1016/j.yexcr.2015.12.012.
［53］CHISTIAKOV D A，BOBRYSHEV Y V，OREKHOV A N.Macrophage-mediated cholesterol handling in atherosclerosis［J］．J Cell Mol Med，2016，20（1）：17-28．DOI：10.1111/jcmm.12689.
［54］IKHLEF S，BERROUGUI H，KAMTCHUENG SIMO O，et al．Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ-LXRα-ABCA1 pathway［J］．FEBS Lett，2016，590（11）：1614-1629．DOI：10.1002/1873-3468.12198.
［55］ZAKIEV E R，SUKHORUKOV V N，MELNICHENKO A A，et al．
Lipid composition of circulating multiple-modified low density lipoprotein［J］．Lipids Health Dis，2016，15（1）：134．DOI：10.1186/s12944-016-0308-2.
［56］NAKANO R，TAKEBE N，ONO M，et al．Involvement of oxidative stress in atherosclerosis development in subjects with sarcopenic obesity［J］．Obes Sci Pract，2017，3（2）：212-218．DOI：10.1002/osp4.97.
［57］FARNAGHI S，PRASADAM I，CAI G P，et al．Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis［J］．FASEB J，2017，31（1）：356-367．DOI：10.1096/fj.201600600R.
［58］CHTOUROU Y，KAMOUN Z，ZARROUK W，et al．Naringenin ameliorates renal and platelet purinergic signalling alterations in high-cholesterol fed rats through the suppression of ROS and NF-κB signaling pathways［J］．Food Funct，2016，7（1）：183-193．DOI：10.1039/c5fo00871a.
［59］LOESER R F，COLLINS J A，DIEKMAN B O.Ageing and the pathogenesis of osteoarthritis［J］．Nat Rev Rheumatol，2016，12（7）：412-420．DOI：10.1038/nrrheum.2016.65.
［60］COLLINS J A，DIEKMAN B O，LOESER R F.Targeting aging for disease modification in osteoarthritis［J］．Curr Opin Rheumatol，2018，30（1）：101-107．DOI：10.1097/BOR.0000000000000456.
［61］KATZ J D，AGRAWAL S，VELASQUEZ M.Getting to the heart of the matter：osteoarthritis takes its place as part of the metabolic syndrome［J］．Curr Opin Rheumatol，2010，22（5）：512-519．DOI：10.1097/BOR.0b013e32833bfb4b.
［62］BARTER M J，HUI W，LAKEY R L，et al．Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation［J］．Ann Rheum Dis，2010，69（12）：2189-2198．DOI：10.1136/ard.2010.129197.
［63］CLOCKAERTS S，VAN OSCH G J，BASTIAANSEN-JENNISKENS Y M，et al．Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study［J］．Ann Rheum Dis，2012，71（5）：642-647．DOI：10.1136/annrheumdis-2011-200092.
［64］GOES P，LIMA N A，RODRIGUES J A，et al．Anti-inflammatory and anti-resorptive effects of atorvastatin on alveolar bone loss in wistar rats［J］．Braz Dent J，2016，27（3）：267-272．DOI：10.1590/0103-6440201600600.
［65］AKASAKI Y，MATSUDA S，NAKAYAMA K，et al．Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation［J］．Osteoarthr Cartil，2009，17（2）：235-243．DOI：10.1016/j.joca.2008.06.012.
［66］SIMOPOULOU T，MALIZOS K N，POULTSIDES L，et al．
Protective effect of atorvastatin in cultured osteoarthritic chondrocytes［J］．J Orthop Res，2010，28（1）：110-115．DOI：10.1002/jor.20953.

[1]	FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063.
[2]	LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949.
[3]	CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807.
[4]	CHEN Yiping, ZHANG Jianmei, LI Yanhu, LI Rui, ZHANG Ruiping, YANG Ping. Advances in the Diagnosis and Treatment of Post-COVID-19 Condition of Myocardial Injury [J]. Chinese General Practice, 2026, 29(18): 2585-2592.
[5]	ZHANG Mingyue, HOU Yan. Research Progress of Exhaled Nitric Oxide and Alveolar Nitric Oxide in Interstitial Lung Diseases [J]. Chinese General Practice, 2026, 29(18): 2571-2576.
[6]	MA Xiaoyu, MA Xiaomei, WU Guozhi, ZHENG Ya, GUO Qinghong. Research Progress of Neutrophil Extracellular Traps in Gastric Cancer [J]. Chinese General Practice, 2026, 29(17): 2425-2432.
[7]	LI Jiawei, GE Aoqi, GAO Xinyi, LI Juanjuan, YUAN Beibei. The Concept, Connotation, and Pathways of the Integration of Medical Care and Preventive Services in China: a Systematic Review [J]. Chinese General Practice, 2026, 29(16): 2156-2166.
[8]	ZHENG Zelu, ZHOU Jun, LIANG Zhi, WANG Xuehui, XU Feng, LI Oujing, XIAO Hong, LIU Xiaoyu, YANG Qingmei, ZHANG Mei, LIN Na, MI Baohong, CHEN Weiheng. Comorbidity Profiles and Treatment Patterns of Osteoarthritis Patients: a Cross-sectional Study Based on Community Medical Records [J]. Chinese General Practice, 2026, 29(16): 2205-2213.
[9]	WANG Yang, JIN Hua, YANG Sen, YANG Hui, YU Dehua. Reconfiguring the Functional Features of Primary Care in a Non-gatekeeping Context: a 15-Year Mixed-methods Systematic Review from China [J]. Chinese General Practice, 2026, 29(16): 2140-2155.
[10]	HE Linqin, LI Xiaodong, LIU Hongpeng, CHEN Qipeng, TANG Zonghan, REN Xaingqian, SONG Hanbing. Acupotomy Inhibits Knee Osteoarthritis Through Activating A3AR to Suppress Chondrocyte Pyroptosis Via the Wnt/β-catenin Signaling Pathway [J]. Chinese General Practice, 2026, 29(15): 2056-2066.
[11]	SHAO Wenjuan, CAI Keshu, JIA Xiao, ZHANG Yimin. Research on the Construction and Application of a Community Intervention Model for Knee Osteoarthritis Based on Sports and Medicine Integration [J]. Chinese General Practice, 2026, 29(13): 1699-1705.
[12]	ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da. Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province [J]. Chinese General Practice, 2026, 29(13): 1759-1765.
[13]	ZHANG Qiang, ZHAO Wenxia, WANG Ziyi, YAN Le, LIANG Haowei, WANG Jinfan, FANG Jinhua, LU Cuncun. Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024) [J]. Chinese General Practice, 2026, 29(13): 1766-1775.
[14]	HE Xiaoming, HE Mincong, WEI Tengfei, LIN Tianye, LIU Wengang, ZHANG Qingwen, HE Wei, WEI Qiushi. Multidimensional Relationship of "TCM Syndrome Type, Clinical Feature and Molecular Typing" in Postmenopausal Patients with Knee Osteoarthritis [J]. Chinese General Practice, 2026, 29(12): 1588-1598.
[15]	YE Xinying, YIN Ankang, LIU Dingling, LYU Xiang, WANG Yi. The Development of General Practice Department in General Hospitals under the DIP Payment Model [J]. Chinese General Practice, 2026, 29(11): 1378-1384.